SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Policies and Practices to Enhance Multi-sectorial Collaborations and Commercialization of Regenerative Medicine
16 references·0 citing·40 second hop
Policies and Practices to Enhance Multi-sectorial Collaborations and Commercialization of Regenerative Medicine (2013)Policies and Practices to Enhance Multi-s…Of Mice and Academics: Examining the Effect of Openness on Innovation (2016)Of Mice and Academics: Examin…Creating the Market University. How Academic Science Became an Economic Engine (2012)Creating the Market Universit…Creating the Market University: How Academic Science Became an Economic Engine (2011)Creating the Market Universit…The Oncomouse That Roared: Hybrid Exchange Strategies as a Source of Distinction at the Boundary of Overlapping Institutions (2010)The Oncomouse That Roared: Hy…How to improve R&D productivity: the pharmaceutical industry's grand challenge (2010)How to improve R&D productivi…Open access chemical and clinical probes to support drug discovery (2009)Open access chemical and clin…Neglected Disease Research and Development: How Much Are We Really Spending? (2009)Neglected Disease Research an…Lessons from 60 years of pharmaceutical innovation (2009)Lessons from 60 years of phar…Where excludability matters: Material versus intellectual property in academic biomedical research (2007)Where excludability matters: …Intellectual property management in health and agricultural innovation : a handbook of best practices (2007)Intellectual property managem…Indicators and outcomes of Canadian university research: Proxies becoming goals? (2006)Indicators and outcomes of Ca…Market value and patent citations (2005)Market value and patent citat…Patent Quality and Research Productivity: Measuring Innovation with Multiple Indicators (2004)Patent Quality and Research P…The NBER Patent Citation Data File: Lessons, Insights and Methodological Tools (2001)The NBER Patent Citation Data…Can Patents Deter Innovation? The Anticommons in Biomedical Research (1998)Can Patents Deter Innovation?…A Penny for Your Quotes: Patent Citations and the Value of Innovations (1990)A Penny for Your Quotes: Pate…Invention and Economic Growth (1966)Geographic Localization of Knowledge Spillovers as Evidenced by Patent Citations (1993)The Increasing Dominance of Teams in Production of Knowledge (2007)Necessity as the mother of ‘green’ inventions: Institutional pressures and environmental innovations (2012)Technological Innovation, Resource Allocation, and Growth* (2017)Little Science, Big Science (1963)R&D, Patents and Productivity (1984)Interorganizational Collaboration and the Locus of Innovation: Networks of Learning in Biotechnology (1996)The price of innovation: new estimates of drug development costs (2003)The black swan: the impact of the highly improbable (2007)Diagnosing the decline in pharmaceutical R&D efficiency (2012)Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework (2014)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Issues in Assessing the Contribution of Research and Development to Productivity Growth (1979)Patent Statistics as Economic Indicators: A Survey (1990)Protecting Their Intellectual Assets: Appropriability Conditions and Why U.S. Manufacturing Firms Patent (or Not) (2000)Identifying Technology Spillovers and Product Market Rivalry (2013)Demand for green finance: Resolving financing constraints on green innovation in China (2021)Economic Welfare and the Allocation of Resources for Invention (1962)Culture in Action: Symbols and Strategies (1986)STRATEGIC RESPONSES TO INSTITUTIONAL PROCESSES (1991)Academic engagement and commercialisation: A review of the literature on university–industry relations (2012)Inside the Hybrid Organization: Selective Coupling as a Response to Competing Institutional Logics (2012)Advancing Research on Hybrid Organizing – Insights from the Study of Social Enterprises (2014)UNDP/World Bank/WHO special programme for research and training in tropical diseases (TDR) (1989)Investments in Pharmaceuticals Before and After TRIPS (2009)The Bill & Melinda Gates Foundation's grant-making programme for global health (2009)Investments in Pharmaceuticals Before and After TRIPS (2011)A Proof for the Queuing Formula: L = λ W (1961)The Goal: A Process of Ongoing Improvement (1984)Can the pharmaceutical industry reduce attrition rates? (2004)Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018 (2020)Judgment under Uncertainty: Heuristics and Biases (1975)Governing the Commons (1990)Governing the Commons: The Evolution of Institutions for Collective Action (1992)Profiting from innovation in the digital economy: Enabling technologies, standards, and licensing models in the wireless world (2018)The Knowledge Economy (2004)Reconsidering the Bayh-Dole Act and the Current University Invention Ownership Model (2009)Startups by recent university graduates and their faculty: Implications for university entrepreneurship policy (2012)Beyond technology transfer: Innovation cooperation to advance sustainable development in developing countries (2021)
this work references cited by second hop

References

  • 2010How to improve R&D productivity: the pharmaceutical industry's grand challenge3,686 cited
  • 2001The NBER Patent Citation Data File: Lessons, Insights and Methodological Tools3,537 cited
  • 2005Market value and patent citations3,383 cited
  • 1990A Penny for Your Quotes: Patent Citations and the Value of Innovations2,963 cited
  • 1998Can Patents Deter Innovation? The Anticommons in Biomedical Research2,646 cited
  • 2004Patent Quality and Research Productivity: Measuring Innovation with Multiple Indicators1,396 cited
  • 2009Lessons from 60 years of pharmaceutical innovation1,238 cited
  • 2010The Oncomouse That Roared: Hybrid Exchange Strategies as a Source of Distinction at the Boundary of Overlapping Institutions412 cited
  • 2007Intellectual property management in health and agricultural innovation : a handbook of best practices304 cited
  • 2009Neglected Disease Research and Development: How Much Are We Really Spending?246 cited
  • 2011Creating the Market University: How Academic Science Became an Economic Engine229 cited
  • 2007Where excludability matters: Material versus intellectual property in academic biomedical research219 cited
  • 2016Of Mice and Academics: Examining the Effect of Openness on Innovation192 cited
  • 2012Creating the Market University. How Academic Science Became an Economic Engine

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

159 cited
  • 2009Open access chemical and clinical probes to support drug discovery130 cited
  • 2006Indicators and outcomes of Canadian university research: Proxies becoming goals?128 cited
  • Cited by

    No citing works inside the corpus for this window.